Secretome Therapeutics Announces $30 Million Series A Financing

North Texas' Secretome Therapeutics Raises $30M Series A to Advance Muscular Dystrophy-Related Drug

Dallas Innovates, Every Day: Here's what's new + next in North Texas. Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies.…The post North Texas’ Secretome Thera…

Secretome Therapeutics Announces $30 Million Series A Financing

Secretome Therapeutics reports the Series A financing from RA Capital supports the advancement of Secretome’s neonatal cardiac progenitor cell platform and late-stage clinical trials of STM-01 in Duchenne muscular dystrophy.